[The early history of "Ecstasy"]
- PMID: 16397805
- DOI: 10.1007/s00115-005-2001-y
[The early history of "Ecstasy"]
Abstract
There is no consensus in the literature regarding the early history of MDMA (Methylendioxymethamphetamine, so-called "Ecstasy"). Various authors credit the first synthesis of MDMA to the German chemist Fritz Haber, but it appears neither in his doctoral thesis (Berlin 1891) nor in his accompanying articles. The man who first synthesized MDMA was the chemist Dr. Anton Köllisch, who worked for the German pharmaceutical company Merck. He created MDMA as a by-product while trying to synthesize hydrastinin, a styptic substance. In 1912, Merck filed to patent the applied method of preparation. The patent was issued in 1914, yet no pharmaceutical testing followed at that time.
Similar articles
-
The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.Addiction. 2006 Sep;101(9):1241-5. doi: 10.1111/j.1360-0443.2006.01511.x. Addiction. 2006. PMID: 16911722
-
The origin of MDMA ("ecstasy")--separating the facts from the myth.Pharmazie. 2006 Nov;61(11):966-72. Pharmazie. 2006. PMID: 17152992 Review.
-
Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin.Addiction. 2010 Aug;105(8):1355-61. doi: 10.1111/j.1360-0443.2010.02948.x. Addiction. 2010. PMID: 20653618
-
The History of MDMA as an Underground Drug in the United States, 1960-1979.J Psychoactive Drugs. 2016 Apr-Jun;48(2):67-75. doi: 10.1080/02791072.2015.1128580. Epub 2016 Mar 3. J Psychoactive Drugs. 2016. PMID: 26940772
-
An exploration of the history and controversies surrounding MDMA and MDA.J Psychoactive Drugs. 2001 Jul-Sep;33(3):213-21. doi: 10.1080/02791072.2001.10400568. J Psychoactive Drugs. 2001. PMID: 11718314 Review.
Cited by
-
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.J Psychopharmacol. 2011 Apr;25(4):439-52. doi: 10.1177/0269881110378371. Epub 2010 Jul 19. J Psychopharmacol. 2011. PMID: 20643699 Free PMC article. Clinical Trial.
-
MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.Diseases. 2023 Nov 3;11(4):159. doi: 10.3390/diseases11040159. Diseases. 2023. PMID: 37987270 Free PMC article. Review.
-
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders.Front Psychiatry. 2022 Apr 25;13:863552. doi: 10.3389/fpsyt.2022.863552. eCollection 2022. Front Psychiatry. 2022. PMID: 35546928 Free PMC article.
-
Can research on entactogens contribute to a deeper understanding of human sexuality?Pharmacol Rep. 2023 Dec;75(6):1381-1397. doi: 10.1007/s43440-023-00552-7. Epub 2023 Nov 8. Pharmacol Rep. 2023. PMID: 37935915 Free PMC article. Review.
-
A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).Neurotoxicol Teratol. 2007 Mar-Apr;29(2):288-300. doi: 10.1016/j.ntt.2006.10.002. Epub 2006 Oct 20. Neurotoxicol Teratol. 2007. PMID: 17174068 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
